Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01683019 · ClinicalTrials.gov registry record · NA
Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major Depression
A NA study, sponsored by Wave Neuroscience.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT01683019 is a NA study that has completed, run by Wave Neuroscience. The registered enrollment target is 52 participants.
The verdict
NCT01683019, a NA study, has completed, sponsored by Wave Neuroscience.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
This feasibility study investigates effects of EEG-based low frequency, low emission magnetic cortical stimulation in comparison to a sham treatment in subjects with moderate to severe depressive disorder.
Interventions
- DEVICE NeoSync EEG Synchronization Therapy
- DEVICE Sham NeoSync EEG Synchronization Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01683019
The ClinicalTrials.gov registry entry for NCT01683019 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wave Neuroscience, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NeoSync EEG Synchronization Therapy is the first listed.
NCT01683019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01683019 about?
NCT01683019 is a clinical study titled "Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major Depression". This feasibility study investigates effects of EEG-based low frequency, low emission magnetic cortical stimulation in comparison to a sham treatment in subjects with moderate to severe depressive disorder.
What is the current status of trial NCT01683019?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2008-06. Estimated completion is 2008-12.
What interventions are being tested in trial NCT01683019?
The interventions under investigation include: NeoSync EEG Synchronization Therapy (DEVICE), Sham NeoSync EEG Synchronization Therapy (DEVICE).
Who is sponsoring clinical trial NCT01683019?
This trial is sponsored by Wave Neuroscience, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.